Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Am J Health Syst Pharm ; 77(15): 1250-1256, 2020 07 23.
Artículo en Inglés | MEDLINE | ID: mdl-34286818

RESUMEN

PURPOSE: The rapid spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has strained the resources of healthcare systems around the world. In accordance with recommendations from the World Health Organization, Centers for Disease Control and Prevention, and US Department of Defense, Intermountain Medical Center (IMED) in Murray, UT, has developed a plan to provide remote clinical pharmacy services to protect the health of pharmacy caregivers while maintaining appropriate clinical pharmacy coverage to optimally care for patients. SUMMARY: The utilization of telemedicine technology permits clinical pharmacists to readily communicate with nurses, physicians, other caregivers, and patients. We have identified strategies to allow clinical pharmacists to continue to participate in daily rounds, provide consultations under collaborative practice agreements, verify medication orders, collect medication histories, provide antimicrobial stewardship, and deliver medication education to patients from off-site locations. The pharmacy department at IMED proactively tested telemedicine technologies, defined the roles of clinical pharmacists, and identified communication strategies prior to a rapid rise in COVID-19 cases in the state of Utah. CONCLUSION: The proactive measures described can help ensure that pharmacy caregivers have appropriate remote access and are capable of confidently using the resources. These steps allow for optimal care of hospitalized patients and promote social distancing, which may have the added benefit of decreasing the spread of SARS-CoV-2 among patients and caregivers.


Asunto(s)
COVID-19/prevención & control , Hospitales Especializados/organización & administración , Servicio de Farmacia en Hospital/organización & administración , Telemedicina/organización & administración , Recursos Humanos/organización & administración , COVID-19/epidemiología , COVID-19/transmisión , Control de Enfermedades Transmisibles/organización & administración , Control de Enfermedades Transmisibles/normas , Comunicación , Humanos , Administración del Tratamiento Farmacológico/organización & administración , Farmacéuticos/organización & administración , Servicio de Farmacia en Hospital/normas , Rol Profesional , Accidente Cerebrovascular/tratamiento farmacológico , Telemedicina/normas , Utah/epidemiología , Heridas y Lesiones/tratamiento farmacológico
2.
Am J Health Syst Pharm ; 76(8): 551-553, 2019 Apr 08.
Artículo en Inglés | MEDLINE | ID: mdl-31420984

RESUMEN

PURPOSE: A cost-reduction strategy for isoproterenol use in radiofrequency catheter ablation procedures was evaluated. SUMMARY: A medication-use evaluation at a 454-bed tertiary medical center revealed that the cardiac catheterization laboratory was the highest user of isoproterenol. Isoproterenol was removed from all AcuDose-Rx machines Omnicell, Mountain View, CA, and compounding was performed by pharmacy personnel. It was initially provided to the cardiac catheterization laboratory as an 8-µg/mL concentration in 20-mL 0.9% sodium chloride injection syringes with a 24-hour beyond-use date. This resulted in an initial cost savings but with an unacceptably high rate of wastage. Isoproterenol was then compounded as a 4-µg/mL concentration in 30 mL 5% dextrose in water syringes with a 9-day beyond-use date after a thorough literature search supported longer stability with this admixture. After 12 months of our current process, isoproterenol use during radio frequency catheter ablations (RFCAs) in the cardiac catheterization laboratory was reduced by 85%, decreasing the number of ampules used from 11.15 to 1.66 per week. CONCLUSION: A pharmacy-initiated process to mitigate an extraordinary increase in isoproterenol acquisition cost resulted in a reduction in usage in a tertiary care community hospital. Isoproterenol usage was reduced 85% after two different interventions were implemented, which is estimated to save $1,839 per procedure.


Asunto(s)
Ablación por Catéter/métodos , Ahorro de Costo , Composición de Medicamentos/métodos , Isoproterenol/economía , Servicio de Farmacia en Hospital/economía , Ablación por Catéter/economía , Ablación por Catéter/instrumentación , Composición de Medicamentos/economía , Costos de los Medicamentos/estadística & datos numéricos , Estabilidad de Medicamentos , Almacenaje de Medicamentos/economía , Registros Electrónicos de Salud/estadística & datos numéricos , Costos de Hospital/estadística & datos numéricos , Humanos , Isoproterenol/administración & dosificación , Estudios Retrospectivos , Centros de Atención Terciaria/economía , Centros de Atención Terciaria/estadística & datos numéricos , Factores de Tiempo
3.
J Pharm Technol ; 33(4): 123-127, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34860882

RESUMEN

Background: There are many benefits to a well-designed prescription process and delivery service at the time of discharge from the hospital. However, the discharge prescription delivery service in our hospital has historically been infrequently utilized. Objective: To assess the number of patients with prescriptions in hand prior to discharge, the number of prescriptions filled, the duration of time to get discharge prescriptions to the floor, and the motivation patients had for declining the service. Methods: This single-center, quality improvement project was initiated as a pilot program from March through December 2015, utilizing a certified pharmacy technician (CPhT) on a 56-bed cardiovascular floor from Monday through Friday, 9:00 am to 5:30 pm. All patients discharged during the pilot time period were included in the analysis. The CPhT was responsible for collecting, inputting, processing, delivering, and charging for discharge prescriptions. Results: The number of patients utilizing the service increased from an average of 68 to 132 per month, pre- and postintervention, respectively. Total prescriptions increased from 296 preintervention to 456 postintervention per month. Prescription delivery time to the patient was decreased by 28 minutes. Conclusions: The utilization of a decentralized CPhT in a 56-bed cardiology unit at a large community hospital increased both the number of patients and total number of prescriptions filled prior to discharge. Future studies are warranted to evaluate medication interventions at discharge and readmission rates in patients who have prescriptions in hand prior to discharge versus those that do not.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...